| Synthesis and Evaluation of N‐Phenylpyrrolamides as DNA Gyrase B Inhibitors M Durcik, P Tammela, M Barančoková, T Tomašič, J Ilaš, D Kikelj, N Zidar ChemMedChem 13 (2), 186-198, 2018 | 66 | 2018 |
| ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents M Durcik, T Tomašič, N Zidar, A Zega, D Kikelj, LP Mašič, J Ilaš Expert opinion on therapeutic patents 29 (3), 171-180, 2019 | 61 | 2019 |
| New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity M Durcik, D Lovison, Ž Skok, CD Cruz, P Tammela, T Tomašič, DB Tiz, ... European journal of medicinal chemistry 154, 117-132, 2018 | 53 | 2018 |
| An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors DB Tiz, Ž Skok, M Durcik, T Tomašič, LP Mašič, J Ilaš, A Zega, ... European journal of medicinal chemistry 167, 269-290, 2019 | 49 | 2019 |
| Rational design of balanced dual-targeting antibiotics with limited resistance A Nyerges, T Tomašič, M Durcik, T Revesz, P Szili, G Draskovits, F Bogar, ... PLoS biology 18 (10), e3000819, 2020 | 33 | 2020 |
| Discovery of novel Hsp90 C-terminal inhibitors using 3D-pharmacophores derived from molecular dynamics simulations T Tomašič, M Durcik, BM Keegan, DG Skledar, Ž Zajec, BSJ Blagg, ... International journal of molecular sciences 21 (18), 6898, 2020 | 33 | 2020 |
| New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens M Durcik, Á Nyerges, Ž Skok, DG Skledar, J Trontelj, N Zidar, J Ilaš, ... European journal of medicinal chemistry 213, 113200, 2021 | 30 | 2021 |
| Discovery and hit-to-lead optimization of benzothiazole scaffold-based DNA gyrase inhibitors with potent activity against Acinetobacter baumannii and Pseudomonas aeruginosa AE Cotman, M Durcik, D Benedetto Tiz, F Fulgheri, D Secci, M Sterle, ... Journal of medicinal chemistry 66 (2), 1380-1425, 2023 | 28 | 2023 |
| Estrogenic potency of endocrine disrupting chemicals and their mixtures detected in environmental waters and wastewaters M Durcik, A Grobin, R Roškar, J Trontelj, LP Mašič Chemosphere 330, 138712, 2023 | 22 | 2023 |
| New dual inhibitors of bacterial topoisomerases with broad-spectrum antibacterial activity and in vivo efficacy against vancomycin-intermediate Staphylococcus aureus M Durcik, AE Cotman, Z Toplak, S Mozina, Z Skok, PE Szili, M Czikkely, ... Journal of medicinal chemistry 66 (6), 3968-3994, 2023 | 21 | 2023 |
| Structure-activity relationships of Benzothiazole-based Hsp90 C-Terminal-domain inhibitors J Dernovšek, Ž Zajec, M Durcik, LP Mašič, M Gobec, N Zidar, T Tomašič Pharmaceutics 13 (8), 1283, 2021 | 19 | 2021 |
| Discovery of new ATP-competitive inhibitors of human DNA topoisomerase IIα through screening of bacterial topoisomerase inhibitors Ž Skok, M Durcik, DG Skledar, M Barančoková, LP Mašič, T Tomašič, ... Bioorganic chemistry 102, 104049, 2020 | 16 | 2020 |
| New bisphenol A and bisphenol S analogs: Evaluation of their hERα agonistic and antagonistic activities using the OECD 455 in-vitro assay and molecular modeling M Durcik, L Hiti, T Tomašič, LP Mašič Chemico-Biological Interactions 354, 109820, 2022 | 14 | 2022 |
| Efficient Synthesis of Hydroxy-Substituted 2-Aminobenzo[d]thiazole-6-carboxylic Acid Derivatives as New Building Blocks in Drug Discovery M Durcik, Z Toplak, N Zidar, J Ilaš, A Zega, D Kikelj, LP Mašič, ... ACS omega 5 (14), 8305-8311, 2020 | 14 | 2020 |
| Hybrid inhibitors of DNA gyrase A and B: design, synthesis and evaluation M Durcik, Ž Skok, J Ilaš, N Zidar, A Zega, PÉ Szili, G Draskovits, T Révész, ... Pharmaceutics 13 (1), 6, 2020 | 13 | 2020 |
| Last piece in the puzzle of bisphenols BPA, BPS and BPF metabolism: Kinetics of the in vitro sulfation reaction M Durcik, DG Skledar, T Tomašič, J Trontelj, LP Mašič Chemosphere 303, 135133, 2022 | 10 | 2022 |
| Practical synthesis and application of halogen-doped pyrrole building blocks AE Cotman, T Guérin, I Kovačević, D Benedetto Tiz, M Durcik, F Fulgheri, ... ACS omega 6 (14), 9723-9730, 2021 | 9 | 2021 |
| ATP-competitive inhibitors of human DNA topoisomerase IIα with improved antiproliferative activity based on N-phenylpyrrolamide scaffold Ž Skok, M Durcik, Ž Zajec, DG Skledar, K Bozovičar, A Pišlar, T Tomašič, ... European journal of medicinal chemistry 249, 115116, 2023 | 6 | 2023 |
| Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens M Sterle, M Durcik, CEM Stevenson, SR Henderson, PE Szili, M Czikkely, ... ACS omega 8 (27), 24387-24395, 2023 | 5 | 2023 |
| Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria M Sterle, E Habjan, M Piga, P Peršolja, M Durcik, J Dernovšek, P Szili, ... European Journal of Medicinal Chemistry 276, 116693, 2024 | 3 | 2024 |
